A non-randomised cohort study to evaluate immunogenicity and reactogenicity of adult formulation diphtheria-tetanus-pertussis vaccine in healthy adult healthcare workers and researchers working with children: a comparison of those who have previously received a booster and those who are previously unvaccinated
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 22 Jun 2017
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Therapeutic Use
- 21 Jun 2017 Planned End Date changed from 1 Dec 2016 to 22 Feb 2018.
- 21 Jun 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 05 Jul 2016 New trial record